Want to see HK:1358 full AI Analyst Report?
1358 Stock Chart & Stats
HK$1.30
HK$0.02(2.06%)
At close: 4:00 PM EST
HK$1.30
HK$0.02(2.06%)
Day’s Range― - ―
52-Week RangeHK$0.97 - HK$1.63
Previous CloseN/A
Volume329.00K
Average Volume (3M)1.12M
Market Cap
HK$1.48B
Enterprise Value-HK$358.96M
Total Cash (Recent Filing)HK$1.81B
Total Debt (Recent Filing)HK$22.01M
Price to Earnings (P/E)14.6
Beta0.26
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.46%
Share Statistics
EPS (TTM)0.06
Shares Outstanding1,442,855,100
10 Day Avg. Volume754,100
30 Day Avg. Volume1,124,400
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)0.44
Price to Sales (P/S)2.13
P/FCF Ratio12.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage provides durable financial flexibility: it lowers refinancing and solvency risk, supports continued R&D/capex funding or dividends during downturns, and gives management capacity to pursue opportunistic M&A or investments without stressing cash flows.
Positive Cash GenerationConsistent positive operating and free cash flow, even if reduced year-over-year, demonstrates the business can self-fund operations and capital needs. That cash generation underpins long-term dividend capacity, reinvestment ability, and resilience to cyclical revenue swings.
Historically Strong Margins & GrowthMulti-year revenue growth and high gross margins reflect durable product economics and likely pricing or mix advantages in medical instruments. These structural margin characteristics support long-term profitability if demand normalizes and operational discipline is maintained.
Bears Say
Recent Revenue DeclineA clear top-line contraction removes momentum behind prior growth and can erode scale benefits. Persisting declines reduce operating leverage, pressure margins and free cash flow, and may require strategic shifts or increased investment to regain market share over the medium term.
Margin CompressionSharp year-over-year margin erosion materially lowers earnings power and cash available for reinvestment or payouts. If structural (pricing, input cost or mix driven), sustained compression could weaken competitive positioning and constrain management's ability to fund growth without raising prices or cutting costs.
Cash Flow Volatility & TransparencyDeclining and uneven free cash flow, plus missing cash-conversion metrics, reduces visibility on earnings quality and financial stability. Volatility complicates capital allocation, dividend planning and stress testing, increasing execution risk over the next several quarters.
PW Medtech Group Ltd. News
1358 FAQ
What was PW Medtech Group Ltd.’s price range in the past 12 months?
PW Medtech Group Ltd. lowest stock price was HK$0.97 and its highest was HK$1.63 in the past 12 months.
What is PW Medtech Group Ltd.’s market cap?
PW Medtech Group Ltd.’s market cap is HK$1.48B.
When is PW Medtech Group Ltd.’s upcoming earnings report date?
PW Medtech Group Ltd.’s upcoming earnings report date is Aug 28, 2026 which is in 44 days.
How were PW Medtech Group Ltd.’s earnings last quarter?
PW Medtech Group Ltd. released its earnings results on Mar 27, 2026. The company reported HK$0.021 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.021.
Is PW Medtech Group Ltd. overvalued?
According to Wall Street analysts PW Medtech Group Ltd.’s price is currently Overvalued.
Does PW Medtech Group Ltd. pay dividends?
PW Medtech Group Ltd. pays a Semiannually dividend of HK$0.02 which represents an annual dividend yield of 7.46%. See more information on PW Medtech Group Ltd. dividends here
What is PW Medtech Group Ltd.’s EPS estimate?
PW Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PW Medtech Group Ltd. have?
PW Medtech Group Ltd. has 1,442,855,100 shares outstanding.
What happened to PW Medtech Group Ltd.’s price movement after its last earnings report?
PW Medtech Group Ltd. reported an EPS of HK$0.021 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.009%.
Which hedge fund is a major shareholder of PW Medtech Group Ltd.?
Currently, no hedge funds are holding shares in HK:1358
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PW Medtech Group Ltd.
Operating within the People's Republic of China, PW Medtech Group Limited is an investment holding company primarily engaged in the medical device industry. The company specializes in the manufacturing and distribution of a diverse portfolio of medical consumables, including various types of infusion sets such as non-PVC, precision filter, and light-resistant models, alongside intravenous cannula products and insulin needles and pens. Beyond its core medical device activities, the group also provides property management services. Established in 1997, the company, previously known as Pyholding Limited, maintains its corporate headquarters in Beijing, China.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―
Options Prices
Currently, No data available
---